(Q49917864)

23 February 2018

title

Combining bedaquiline and delamanid to treat multidrug-resistant tuberculosis (English)

1 reference

23 February 2018

main subject

multiple drug resistance

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29452940%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Simon Tiberi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29452940%20AND%20SRC:MED&resulttype=core&format=json

Giovanni Battista Migliori

3 June 2020

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29452940%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

author name string

Marina Tadolini

series ordinal

1

1 reference

23 February 2018

publication date

13 February 2018

1 reference

23 February 2018

Lancet Infectious Diseases

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29452940%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29452940%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29452940%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

480-481

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29452940%20AND%20SRC:MED&resulttype=core&format=json

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.

3 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930106-3

7 January 2021

Final treatment outcomes of multidrug- and extensively drug-resistant tuberculosis patients in Latvia receiving delamanid-containing regimens

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930106-3

7 January 2021

Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930106-3

7 January 2021

Multidrug-resistant tuberculosis and beyond: an updated analysis of the current evidence on bedaquiline

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930106-3

7 January 2021

Compassionate and optimum use of new tuberculosis drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930106-3

7 January 2021

First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930106-3

7 January 2021

Bedaquiline plus delamanid for XDR tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930106-3

7 January 2021

Cardiac safety of extensively drug-resistant tuberculosis regimens including bedaquiline, delamanid and clofazimine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930106-3

7 January 2021

Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930106-3

7 January 2021

Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930106-3

7 January 2021

Cardiac safety of bedaquiline: a systematic and critical analysis of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930106-3

7 January 2021

10.1016/S1473-3099(18)30106-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29452940%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

1 reference